Stock listing

NASDAQ:RGLS Regulus Therapeutics Inc Stock

Follow Regulus Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RGLS

$8.16 USD

Close on Jun 24, 2025 · No longer trades

Jun 29, 2022 to last close +288.6% · weekly closes, Jun 29, 2022 – Jun 24, 2025
Lowest – highest close
$0.793 – $8.30 USDSince Jun 29, 2022 · lowest Mar 27, 2023 · highest Jun 9, 2025

Delisted NASDAQ:RGLS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RGLS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Regulus Therapeutics Inc on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
Decks
4 decks · latest Mar 27, 2025

Events

CallWhenStatus
Regulus Therapeutics (RGLS) Q3 2022 Earnings CallThu, Nov 10, 2022 · 5:00 PM ETReplay
Regulus Therapeutics (RGLS) Q2 2022 Earnings CallThu, Aug 11, 2022 · 5:00 PM ETReplay
Regulus Therapeutics (RGLS) Q1 2022 Earnings CallThu, May 12, 2022 · 5:00 PM ETReplay
Regulus Therapeutics (RGLS) Q4 2021 Earnings CallThu, Mar 10, 2022 · 5:00 PM ETReplay
Regulus Therapeutics (RGLS) Q3 2021 Earnings CallWed, Nov 10, 2021 · 5:00 PM ETReplay
Regulus Therapeutics (RGLS) Q2 2021 Earnings CallTue, Aug 10, 2021 · 5:00 PM ETReplay
Regulus Therapeutics (RGLS) Q1 2021 Earnings CallThu, May 13, 2021 · 5:00 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (March 2025)Technical10 slidesMar 27, 2025
Investor Presentation (October 2021)Investor deck36 slidesOct 18, 2021
Rare & Orphan Disease Summit (May 2021)Conference30 slidesMay 21, 2021
Investor Presentation (December 2020)Investor deck43 slidesDec 1, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John M. Maraganore
Other companies: City Therapeutics, Inc. (Executive Chair · Since at least Oct 19, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Jan 29, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Jun 6, 2024); Kymera Therapeutics, Inc. (Director · Since at least Jan 17, 2022); Beam Therapeutics Inc. (Board Member · Since at least Nov 5, 2021); Alnylam Pharmaceuticals, Inc. (Director · Since at least May 12, 2006); Instil Bio, Inc. (Director · Jun 11, 2025 – Nov 4, 2026 · Past); ProKidney Corp. (Director · Jul 11, 2022 – Jun 29, 2023 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Dec 31, 2022 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Sep 14, 2017 · Past)
Director · Oct 4, 2012 – Oct 10, 2012 · Past
Douglas E. Williams
Other companies: CAMP4 Therapeutics Corporation (Chairman of the Board · Since at least Mar 17, 2025); Climb Bio, Inc. (Chairman · Since at least Nov 8, 2024); Sana Biotechnology, Inc. (EVP & President, R&D · Apr 10, 2023 – Mar 7, 2024 · Past); Panacea Acquisition II Corp (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Codiak BioSciences Inc (President & CEO, Director · Oct 13, 2020 – Mar 28, 2023 · Past); Ovid Therapeutics Inc. (Director · May 4, 2017 – May 17, 2021 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2014 – Apr 1, 2019 · Past); Biogen Inc. (EVP Research & Development · Jan 10, 2011 – Jun 19, 2015 · Past); Cascadian Therapeutics Inc (Director · Oct 1, 2009 – Jun 13, 2013 · Past); Anadys Pharmaceuticals Inc (Director · Jun 2, 2006 – May 30, 2008 · Past)
Director · Nov 5, 2012 – Jun 2, 2016 · Past
Barry Greene
Other companies: Dyne Therapeutics, Inc. (Board Member · Since at least Jun 22, 2026); Sage Therapeutics Inc (President and CEO, Director · Since at least Sep 30, 2020); Karyopharm Therapeutics Inc. (Director · Since at least Nov 5, 2013); BCLS Acquisition Corp (Director · Oct 22, 2020 – Oct 22, 2020 · Past); Acorda Therapeutics Inc (Director · Jan 9, 2007 – Jun 2, 2021 · Past); Alnylam Pharmaceuticals, Inc. (President · Oct 31, 2006 – Sep 9, 2020 · Past)
Director · Oct 4, 2012 – Nov 5, 2012 · Past
Paul Edward Walker
Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Trevi Therapeutics, Inc. (Director · May 7, 2019 – May 7, 2019 · Past); Marker Therapeutics, Inc. (Director · Oct 17, 2018 – Oct 17, 2018 · Past); Allakos Inc (Director · Jul 18, 2018 – May 15, 2025 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jun 2, 2014 · Past)
Director · May 7, 2019 – May 7, 2019 · Past
William H. Rastetter
Other companies: Iambic Therapeutics, Inc. (Board Chair · Since at least Oct 16, 2026); Dare Bioscience, Inc. (Chairman of the Board · Since at least Apr 10, 2014); Fate Therapeutics, Inc. (Chairman · Since at least Sep 30, 2013); Neurocrine Biosciences, Inc. (Director · Since at least Feb 4, 2010); Receptos Inc (Director · May 8, 2013 – Aug 25, 2015 · Past); Illumina, Inc. (Director · Jun 8, 2006 – Dec 31, 2015 · Past)
Director · Since at least Apr 1, 2013
Bruce L.A. Carter
Other companies: Enanta Pharmaceuticals, Inc. (Chairman of the Board · Since at least Nov 22, 2013); ALSP Orchid Acquisition I Corp (Director · Nov 18, 2021 – Nov 18, 2021 · Past); Xencor, Inc. (Director · Dec 2, 2013 – Jun 14, 2017 · Past); Novelion Therapeutics Inc (Director · Nov 28, 2006 – May 26, 2011 · Past); Renovis Inc (Director · Jan 16, 2006 – May 2, 2008 · Past)
Director · Oct 4, 2012 – Jun 10, 2015 · Past
Garry E. Menzel
Other companies: Adaptimmune Therapeutics PLC (Non-Executive Director · Since at least Jun 1, 2023); Stoke Therapeutics, Inc. (Director · Since at least Aug 13, 2020); Black Diamond Therapeutics, Inc. (Operating Partner, GHO Capital Partners LLP · Since at least Jan 29, 2020); Tcr2 Therapeutics Inc (President and CEO, Director · Feb 13, 2019 – Jun 1, 2023 · Past); DaVita Inc. (Senior Vice President, Finance · Sep 9, 2013 – Sep 9, 2013 · Past)
COO & Executive VP, Finance · Oct 4, 2012 – Dec 11, 2012 · Past
Lynne Parshall
Other companies: Foghorn Therapeutics Inc. (Director, Ionis Pharmaceuticals · Since at least Aug 16, 2022); Cytokinetics, Incorporated (Director · Since at least Feb 7, 2013); Ionis Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2006); Akcea Therapeutics Inc (Director · Jul 13, 2017 – Oct 12, 2020 · Past); Cardiodynamics International Corp (Director · Jul 20, 2006 – Aug 14, 2009 · Past)
Director · Oct 4, 2012 – Nov 3, 2014 · Past
Preston Klassen
Other companies: Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past); Orexigen Therapeutics Inc (EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past)
President & Head of R & D, Director · Since at least Jun 12, 2023
Stelios Papadopoulos
Other companies: Ovid Therapeutics Inc. (Director, Member of the Audit and Compensation Committees · Since at least Mar 1, 2025); Exelixis, Inc. (Chair of the Board, Exelixis, Inc. · Since at least May 24, 2012); BG Medicine Inc (Director · Since at least Nov 9, 2011); Eucrates Biomedical Acquisition Corp. (Director · Oct 23, 2020 – Nov 24, 2020 · Past); Biogen Inc. (Director · Jun 8, 2012 – Jun 15, 2022 · Past)
Director · Since at least Oct 4, 2012
All 27 people
PersonSeat
Mark Foletta
Other companies: Enanta Pharmaceuticals, Inc. (Director · Since at least Jun 29, 2020); AMN Healthcare Services Inc (Director · Since at least Nov 27, 2017); DexCom, Inc. (Director · Since at least Nov 27, 2017); Tocagen Inc (EVP & Chief Financial Officer · Dec 8, 2017 – Oct 4, 2019 · Past)
Director · Dec 4, 2017 – Dec 4, 2017 · Past
David Szekeres
Other companies: Connect Biopharma Holdings Limited (PRESIDENT · Since at least Mar 31, 2025); GRI Bio, Inc. (Director · Since at least Apr 21, 2023); Heron Therapeutics, Inc. (EVP, Chief Operating Officer · Oct 13, 2020 – Jul 13, 2023 · Past)
Chief Business Officer & GC · Mar 10, 2014 – Dec 2, 2014 · Past
Jason Raleigh Nunn
Other companies: Addex Therapeutics Ltd (Director · Since at least Mar 18, 2026); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Trevena, Inc. (Director · May 16, 2019 – Jun 13, 2024 · Past)
Director · Since at least Jun 6, 2019
Joseph P Hagan
Other companies: Aurinia Pharmaceuticals Inc (Director · Jun 14, 2021 – May 18, 2023 · Past); Zosano Pharma Corp (Director · May 22, 2015 – Jun 10, 2021 · Past); Orexigen Therapeutics Inc (Chief Business Officer · May 27, 2009 – Feb 3, 2015 · Past)
Chief Executive Officer, Director · Since at least Jan 4, 2016
Neil Gibson
Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past)
Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past
Pascale Witz
Other companies: Revvity, Inc. (Director · Since at least Oct 27, 2017); Tesaro Inc (Director · May 10, 2018 – Jan 22, 2019 · Past); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past)
Director · Since at least Jun 1, 2017
Daniel R Chevallard
Other companies: LENZ Therapeutics, Inc. (Chief Financial Officer · Since at least Mar 21, 2024); Viracta Therapeutics Inc (CFO and COO · Mar 26, 2021 – Mar 12, 2024 · Past)
Chief Financial Officer · May 4, 2017 – Jul 1, 2019 · Past
David Baltimore
Other companies: Amgen Inc. (Director · Mar 30, 2016 – Apr 27, 2018 · Past); Immune Design Corp (Director · Jan 4, 2016 – Apr 2, 2019 · Past)
Director · Since at least Jun 2, 2016
Stanley T Crooke
Other companies: Akcea Therapeutics Inc (Director · Jul 13, 2017 – Jul 13, 2017 · Past); Ionis Pharmaceuticals, Inc. (Exec Chairman of the Board, Director · Jan 3, 2006 – Jan 26, 2021 · Past)
Director · Oct 4, 2012 – Nov 5, 2012 · Past
Simos Simeonidis
Other companies: Sarissa Capital Acquisition Corp (Senior Managing Director · Oct 20, 2020 – Oct 20, 2020 · Past)
Director · Jun 6, 2019 – Jun 9, 2022 · Past
Timothy Michael Wright
Other companies: Schrodinger, Inc. (Director · Feb 5, 2020 – Feb 10, 2020 · Past)
Chief R & D Officer · Dec 4, 2017 – Feb 5, 2019 · Past
Alice Shih-hou HuangDirector · Since at least Jan 6, 2021
Christopher Ray AkerSr. VP & General Counsel · Since at least Jan 1, 2019
Crispina CalsadaChief Financial Officer · Since at least Aug 30, 2019
Denis DryginChief Scientific Officer · Aug 3, 2020 – Mar 1, 2022 · Past
Hugh RosenDirector · Since at least Jun 2, 2016
Kathryn J CollierDirector · Since at least Apr 14, 2018

Open People

Log in to ask 6ix AI your own questions about Regulus Therapeutics Inc.